Innovative DES technologies from Meril.
Technological advances and rise in global urbanity have paradoxically led to an increase in the incidence of metabolic syndrome and thankfully also in diagnosis and treatment of coronary artery disease. "Necessity is the mother of invention" - remarked Plato and this statement could not have had a better place than in the field of angioplasty and stenting. Interventional cardiology still continues to remain a busy place for smart, iterative changes leading to better treatment options. This article sketches contemporary trends in coronary stent engineering borne out of unmet clinical needs ranging from novel ultra-thin strut designs marrying biodegradable polymeric drug eluting platforms to anatomically tapered stents and finally the intuitive bioresorbable vascular scaffolds which promise freedom from full metal jacket.
Meril Life Sciences, Gujarat, India - maurodebenedictis@yahoo.it.
S
S
Bhatt
S
S
Gujarathi
M
M
De Benedictis
D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000601:surgery*; D054855:Drug-Eluting Stents; D006801:Humans; D011108:Polymers / Q000737:chemistry; D011474:Prosthesis Design; D054457:Tissue Scaffolds
D011108:Polymers